Valuation: Square Pharmaceuticals PLC.

Market Cap 194B 1.56B 1.4B 1.28B 1.16B 2.19B 146B 2.26B 15.37B 6.13B 78.02B 5.84B 5.71B 246B P/E 2026 *
7.39x
P/E 2027 * 6.58x
Enterprise Value 194B 1.56B 1.4B 1.28B 1.16B 2.19B 146B 2.26B 15.37B 6.13B 78.02B 5.84B 5.71B 246B EV / Sales 2026 *
2.28x
EV / Sales 2027 * 2.05x
Free-Float
55.9%
Yield 2026 *
-
Yield 2027 * -
1 day+0.97%
1 week+0.09%
Current month+0.09%
1 month+0.78%
3 months-0.59%
6 months+3.99%
Current year+10.12%
1 week 213.8
Extreme 213.8
219
1 month 213.8
Extreme 213.8
220.7
Current year 198.1
Extreme 198.1
236
1 year 198
Extreme 198
236
3 years 197.2
Extreme 197.2
249.8
5 years 197.2
Extreme 197.2
249.8
10 years 149.05
Extreme 149.047619
278.67
Manager TitleAgeSince
Chief Executive Officer - 1994-12-31
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman - 2011-12-31
Director/Board Member - 1979-12-31
Director/Board Member - 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+0.09%+2.92%+3.70% 1.56B
-0.79%-4.48%+44.44%+127.49% 1,216B
+1.43%+1.11%+47.73%+82.08% 656B
+1.07%-1.21%+32.99%+106.31% 509B
-0.36%-3.25%+47.17%+64.58% 384B
-0.14%-1.87%+71.05%+40.63% 362B
-0.78%-0.52%+30.57%+57.98% 311B
-0.80%-0.21%+8.54%+35.56% 293B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 208B
Average +0.02%-0.30%+36.66%+69.28% 418.94B
Weighted average by Cap. -0.05%-1.21%+42.19%+88.32%

Financials

2026 *2027 *
Net sales 85.11B 683M 613M 560M 511M 963M 64.2B 993M 6.75B 2.69B 34.25B 2.56B 2.51B 108B 94.79B 761M 682M 623M 569M 1.07B 71.49B 1.11B 7.51B 3B 38.15B 2.85B 2.79B 120B
Net income 26.6B 213M 191M 175M 160M 301M 20.06B 310M 2.11B 841M 10.71B 801M 784M 33.8B 29.57B 237M 213M 194M 178M 334M 22.3B 345M 2.34B 935M 11.9B 891M 872M 37.57B
Net Debt - -
Projected Income Statement - Annual - Square Pharmaceuticals PLC.
Logo Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.
Employees
15,937
Date Price Change Volume
26-11-05 BDT 218.70 +0.97% 278,279
26-11-04 BDT 216.60 +0.46% 323,813
26-11-03 BDT 215.60 -0.37% 384,818
26-11-02 BDT 216.40 -0.69% 208,680
26-11-01 BDT 217.90 -0.27% 180,236
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Square Pharmaceuticals PLC.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
218.70BDT
Average target price
352.20BDT
Spread / Average Target
+61.04%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Square Pharmaceuticals PLC.
  1. Stock Market
  2. Stocks
  3. SQURPHARMA Stock